Harrow Stock (NASDAQ: HROW) stock price, news, charts, stock research, profile.
Open | $12.760 |
Close | $13.230 |
Volume / Avg. | 838.708K / 440.085K |
Day Range | 12.700 - 13.480 |
52 Wk Range | 7.600 - 28.250 |
Market Cap | $477.396M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 75 |
Short Interest | 18.63% |
Days to Cover | 19.59 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Harrow (NASDAQ: HROW) through any online brokerage.
Other companies in Harrow’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD) and GH Research (NASDAQ:GHRS).
The latest price target for Harrow (NASDAQ: HROW) was reported by B. Riley Securities on Friday, March 22, 2024. The analyst firm set a price target for 26.00 expecting HROW to rise to within 12 months (a possible 92.59% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Harrow (NASDAQ: HROW) is $13.5 last updated March 28, 2024 at 7:38 PM EDT.
There are no upcoming dividends for Harrow.
Harrow’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for Harrow.
Harrow is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.